Home › Trial NCT00812240
Masitinib in First Line Treatment of Gastro-Intestinal Stromal Tumor (GIST)
- Trial IDNCT00812240
- StatusTerminated
- PhasePhase 3
- Study typeInterventional
- SponsorAB Science
- Enrollment335
- Start date2009-01
- ConditionsGastrointestinal Stromal Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.